Liquidia Corporation Common Stock vs PBF Energy Inc. Class A Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.69 (market cap $2.40B), while PBF Energy Inc. Class A Common Stock trades at $89.57 (market cap $10.81B). The key difference: PBF Energy Inc. Class A Common Stock is far larger — about 4.5× Liquidia Corporation Common Stock's market cap, and PBF Energy Inc. Class A Common Stock pays a 1.21% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and PBF Energy Inc. Class A Common Stock for 1 Days on average.
| LQDA | PBF | |
|---|---|---|
Market Cap | $2.40B | $10.81B |
Volume | 2,857,547 | 3,399,980 |
Sector | Health | Energy |
52-Week High | $91.03 | $91.17 |
52-Week Low | $22.02 | $26.02 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $2.30B | $12.43B |
Dividend Yield | — | 1.21% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PBF Energy trades at $91.17, up 7.23% in the last 24 hours and near its 52-week high, reflecting strong bullish momentum. The stock shows robust technical strength with a bullish moving average signal and trades above key support levels. Fundamentally, the company is transitioning from a net loss of $158.5 million in 2025 to a projected net profit of $1.4 billion in 2026, driven by restored refinery operations and significant debt reduction. Recent earnings beats, including a Q2 2026 EPS of $6.22 versus $4.15 expected, highlight operational improvements.
The outlook for PBF is positive with strong earnings growth and discounted valuation metrics, but risks include volatile refining margins and geopolitical influences on oil prices. Analyst sentiment is mixed with a consensus price target of $88.75, below the current price, suggesting caution despite the bullish technical setup. Investors should weigh the strong profitability rebound against potential headwinds from energy market fluctuations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →PBF Energy refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics assets supporting its refining business.
Read more on PBF →